Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 12
2004 12
2005 14
2006 11
2007 16
2008 14
2009 9
2010 9
2011 20
2012 12
2013 17
2014 21
2015 14
2016 20
2017 24
2018 35
2019 32
2020 33
2021 31
2022 26
2023 32

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Among authors: sakamoto t. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Sakamoto T, Terasaki H. Sakamoto T, et al. Retina. 2016 Feb;36(2):e15. doi: 10.1097/IAE.0000000000000943. Retina. 2016. PMID: 26689272 No abstract available.
Silicone oils compared and found wanting.
Steel DHW, Wong D, Sakamoto T. Steel DHW, et al. Among authors: sakamoto t. Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):11-12. doi: 10.1007/s00417-020-04810-9. Epub 2020 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32572605 No abstract available.
What COVID-19 has taught us: lessons from around the globe.
Koh AHC, Koh LRS, Sheu SJ, Sakamoto T. Koh AHC, et al. Among authors: sakamoto t. Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2091-2094. doi: 10.1007/s00417-020-04791-9. Epub 2020 Jun 13. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32535670 Free PMC article. No abstract available.
Hyalocyte origin, structure, and imaging.
Wieghofer P, Engelbert M, Chui TY, Rosen RB, Sakamoto T, Sebag J. Wieghofer P, et al. Among authors: sakamoto t. Expert Rev Ophthalmol. 2022;17(4):233-248. doi: 10.1080/17469899.2022.2100762. Epub 2022 Sep 6. Expert Rev Ophthalmol. 2022. PMID: 36632192 Free PMC article.
Lens regeneration in children.
Vavvas DG, Dryja TP, Wilson ME, Olsen TW, Shah A, Jurkunas U, Pineda R, Poulaki V, Palioura S, Veldman P, Moreno-Montañés J, Pinazo-Duran MD, Pastor JC, Tsilimbaris M, Rhee D, Colby K, Hunter DG, Thanos S, Sakamoto T, Pasquale LR, Miller JW, VanderVeen D, Lambert SR. Vavvas DG, et al. Among authors: sakamoto t. Nature. 2018 Apr 4;556(7699):E2-E3. doi: 10.1038/nature26149. Nature. 2018. PMID: 29620729 No abstract available.
379 results